Formulation Development of a Nucleotide Phosphoramidate

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-06-02-2003
Volume 27
Issue 6

A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.

Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Related Content